The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial
Official Title: 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial
Study ID: NCT06232577
Brief Summary: To compare 2 different models for prescribing opioid pain medication to provide better pain control to participants with an abdominal cancer who are having surgery.
Detailed Description: Primary Objectives: The co-primary objectives of this study are as follows: 1. To determine differences in the initial OME prescribed upon discharge between each algorithm/model. 1. To determine OME usage by day 14 after hospital discharge. Secondary Objectives: Secondary objectives are as follows: 1. To determine rates of patients with zero OME upon discharge. 2. To determine rates of OME refill requests and completions at 15- and 30-days post-operation. 3. To determine number of unused or leftover pills at 15- and 30-days post- operation 4. To determine persistent opioid use at 30-days, 3-months, and 6-months post-operation 5. To elucidate patient, prescriber, and oncologic factors predictive of persistent opioid use 6. To assess quality of life using patient-reported outcomes at 30-days, 3-months, and 6-months post-operation. 7. To determine patient satisfaction with either prescribing model.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
MD Anderson Cancer Center, Houston, Texas, United States
Name: Ching-Wei D Tzeng, MD
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR